These innovations will not only make treatment easier for millions of people but also expand the scope of obesity management to a truly precision-medicine approach
Menopause brings various health changes driven by shifts in hormones, metabolism, and body composition
Results In all, 39 pwIIH (mean age 33.6 years [SD 8.0], 92.3% female, median BMI 36.3 kg/m 2 [IQR 31.438.3]) were included, with 13 pwIIH being treated with GLP-1-RAs and remaining adherent to the treatment throughout the study
Some stay at this dose indefinitely, while others continue to the maximum
If users saw no change in the first 14 days, they routinely bumped up their dose, switched injection sites, or questioned if their peptide was real